Deep learning to diagnose and assess Alzheimer's disease
Part of Brain & nervous system, Mental health clinical trials.
This study uses advanced computer models (deep learning) to analyze brain images and help diagnose Alzheimer's disease earlier and more accurately. If you have mild cognitive impairment or early-to-moderate Alzheimer's, you may be able to help improve how doctors identify and track the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 85 years old.
- You finished at least primary school and speak Mandarin as your main language.
- You have a diagnosis of Alzheimer's disease or mild cognitive impairment.
- Your last memory/thinking test (MMSE) score is between 10 and 28, and your dementia stage (CDR) is not higher than 2.
- You do not have other major brain or body conditions that could explain your memory loss (like depression, Parkinson's, or severe vitamin deficiency).
- You are willing and able to have an MRI scan and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for brain/biological “signals” (biomarkers) that may identify Alzheimer’s disease earlier, including stages before clear symptoms. You may be followed for about 5 years, with repeated memory and thinking testing to see how these signs relate to future diagnosis.
This study uses digital tools and blood tests to check for early signs of memory problems in healthy older adults living in the community. The goal is to find people who might be at risk for conditions like Alzheimer's disease before symptoms get worse.
This study uses advanced brain scans (MRI and molecular imaging) to get a clearer picture of dementia and mild cognitive impairment (MCI). It aims to learn more about how the brain changes in these conditions, which could help improve diagnosis and treatment.
This study uses artificial intelligence to find early signs of Alzheimer's disease in people who feel their memory is getting worse but still score normally on memory tests. It may help detect the disease earlier and improve treatment options.
This study uses computer and touch-screen tasks to measure thinking changes in people who may be in the early, symptom-free stage of Alzheimer’s disease. It aims to understand how these brain-related changes show up on testing, which could help future detection or tracking.
This study uses MRI brain scans and memory tests to help detect early Alzheimer’s disease. It compares people with Alzheimer’s (diagnosed by a clinician) with people without memory problems to see which scan and test results stand out.
Hear when a new Mild Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.